课题基金 / 基金详情

Analysis of the candidate tumor suppressor ING1 gene in breast cancer.

Analysis of the candidate tumor suppressor ING1 gene in breast cancer.
乳腺癌候选抑癌基因 ING1 的分析。
批准号:
12671167
负责人:
TOYAMA Tatsuya
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

TOYAMA Tatsuya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Down regulation of the ING1 candidate tumor suppressor promotes growth in soft agar and focus formation in vitro and tumor formation in vivo. ING1 encodes a nuclear, cell cycle-regulated protein that cooperates with p53 in the negative regulation of cell growth by transcriptionally activating the p21 gene. Overexpression of ING1 efficiently blocks cell growth and is capable of inducing apoptosis in different experimental systems. Here we present the first report of ING1mutation and expression analysis in a total of 502 cancer samples. One germline missense alteration and 3 germline silent alterations were detected in 427 primary breast cancers while marked (2-10-fold) decreases in ING1 mRNA expression were seen in 44 % of primary breast cancers and in 10 of 10 breast cancer cell lines examined. Furthermore, the majority of breast cancers (58 %) showing decreased ING1 expression had matastasized to regional lymph nodes whereas only 9 % of cancers with elevated ING1 expression, compared to adjacent normal tissues, were metastatic, Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumor development of breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Estrogen receptor knock down therapy using microRNA for breast cancer patients
  • 批准号:
    21591674
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2009
  • 负责人:
    TOYAMA Tatsuya
  • 依托单位:
The role of co-factor of estrogen receptor alfa in breast cancer cells
海外基金